| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |